Submitted by Anonymous (not verified) on 25 July 2024 - 13:55
Human medicines European public assessment report (EPAR): Symtuza, darunavir,cobicistat,emtricitabine,tenofovir alafenamide, Date of authorisation: 21/09/2017, Revision: 18, Status: Authorised
Source: